Andlauer Healthcare Group (AND) Q1 2025 earnings summary

Executive summary

• Revenue grew 3.1% year-over-year to $166.1M in Q1 2025, driven by organic growth in Canadian transportation and logistics, with both healthcare logistics and specialized transportation segments contributing despite US truckload headwinds and Nova Pack deconsolidation.

• Net income rose to $20.2M from $14.9M, aided by a $5.0M gain on the Nova Pack deconsolidation; excluding this, net income was $15.2M.

• EBITDA, excluding the Nova Pack gain, was $40.0M (24.1% margin), slightly up from $39.6M (24.6%) in Q1 2024.

• Announced a definitive agreement for acquisition by UPS in an all-cash deal valuing the company at $2.2B ($55.00/share), pending shareholder and regulatory approvals.

Financial highlights

• Operating income increased 1.5% to $21.6M; net income up 35.6% to $20.2M, including the Nova Pack gain.

• Healthcare logistics revenue rose 8.8% to $46.6M, driven by logistics/distribution growth; specialized transportation revenue up 1.0% to $119.5M.

• Cost of transportation/services was $84.8M (51.0% of revenue); direct operating expenses $26.6M (16.0% of revenue).

• SG&A expenses increased to $15.2M (9.1% of revenue), reflecting higher legal/professional fees for the JV and UPS transaction.

• Earnings per share (diluted) were $0.51, or $0.38 excluding the Nova Pack gain, compared to $0.35 in Q1 2024.

Outlook and guidance

• UPS acquisition expected to close in H2 2025, subject to approvals; AHG shares to be delisted post-transaction.

• Management expects continued organic growth in Canadian operations; US truckload business remains challenged.

• Quarterly dividend of $0.12 per share expected until transaction close, subject to financial and legal considerations.